Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Heterozygous variants in the paired box gene PAX6 are implicated in Peters anomaly, a dominantly inherited anterior segment dysgenesis. Three unrelated patients have been reported with de novo or familial PAX6 missense mutations in Peters anomaly: c.51C>A (p.Asn17Lys) (PMID:20405024), c.155G>A (p.Cys52Tyr) (PMID:25182519), and c.194G>T (p.Gly65Val) (PMID:24281366). Each variant affects a highly conserved residue within the paired or homeodomain and was absent in unaffected controls, supporting pathogenicity.
Functional assays demonstrate that PAX6 missense alleles, such as p.Arg26Gly, impair DNA binding at paired-domain consensus sites and reduce transactivation, consistent with a hypomorphic mechanism leading to anterior segment maldevelopment (PMID:9147640). While segregation data are limited, the concordance of variant absence in controls and functional impairment provides moderate experimental support. Additional reports and larger pedigrees will be needed to elevate the evidence beyond the current limited genetic series. Key Take-home: PAX6 heterozygous missense variants should be considered in the genetic evaluation of Peters anomaly.
Gene–Disease AssociationLimitedThree unrelated probands with heterozygous PAX6 missense variants in Peters anomaly (PMID:20405024; 25182519; 24281366) Genetic EvidenceLimitedThree unrelated probands with heterozygous deleterious variants: c.51C>A (p.Asn17Lys)(PMID:20405024), c.155G>A (p.Cys52Tyr)(PMID:25182519), c.194G>T (p.Gly65Val)(PMID:24281366) Functional EvidenceModerateIn vitro functional assays demonstrate hypomorphic and impaired DNA-binding of PAX6 missense variants (p.Arg26Gly) consistent with Peters anomaly phenotype (PMID:9147640) |